MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

Filter Criteria [Hide filter]
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
Too much news? Try filtering with NewsWatch. Alternatively, try our Desktop News Alert.

The following articles are from the past month only. Click here for older news.
 
First     Previous    
27/10/22 14:27 Hutchmed (China) Limited (HCM) IN BRIEF: Hutchmed begins phase II/III trial of fruquintinib ALN
10/10/22 10:24 Hutchmed (China) Limited (HCM) Hutchmed begins sovleplenib trial for anaemia treatment in China ALN
08/09/22 11:02 Hutchmed (China) Limited (HCM) Hutchmed posts positive results for CRC cancer treatment ALN
09/08/22 10:04 Hutchmed (China) Limited (HCM) Hutchmed notes dosing of first participant in IMG-004 study ALN
08/08/22 11:32 Hutchmed (China) Limited (HCM) UPDATE: Hutchmed, AstraZeneca move lung cancer drug to phase 3 trial ALN
08/08/22 09:17 Hutchmed (China) Limited (HCM) Hutchmed regulatory submission underway as fruquintinib trial succeeds ALN
15/07/22 13:20 Hutchmed (China) Limited (HCM) IN BRIEF: Hutchmed starts phase I trial of HMPL-A83 ALN
13/07/22 09:35 Hutchmed (China) Limited (HCM) IN BRIEF: Hutchmed presents solid results from lung cancer study ALN
06/07/22 09:25 Hutchmed (China) Limited (HCM) Hutchmed phase I trial for IMG-007 doses first patient ALN
01/06/22 10:07 Hutchmed (China) Limited (HCM) IN BRIEF: Hutchmed China wins cancer drug Tazverik approval in Hainan ALN
03/05/22 11:25 Hutchmed (China) Limited (HCM) IN BRIEF: US FDA says Hutchmed's pancreatic drug needs more testing ALN
22/04/22 06:08 (HCM) Director Deals - (HCM) BFN
22/04/22 06:08 (HCM) Director Deals - (HCM) BFN
22/04/22 06:08 (HCM) Director Deals - (HCM) BFN
22/04/22 06:08 (HCM) Director Deals - (HCM) BFN
22/04/22 06:08 (HCM) Director Deals - (HCM) BFN
22/04/22 06:08 (HCM) Director Deals - (HCM) BFN
22/04/22 06:08 (HCM) Director Deals - (HCM) BFN
31/03/22 11:43 Hutchmed (China) Limited (HCM) IN BRIEF: Hutchmed China named by SEC, might delist Nasdaq shares ALN
11/03/22 10:38 Hutchmed (China) Limited (HCM) IN BRIEF: Hutchmed China shares fall as US listing under threat ALN
09/03/22 15:07 (HCM) Director Deals - (HCM) BFN
09/03/22 15:07 (HCM) Director Deals - (HCM) BFN
09/03/22 15:07 (HCM) Director Deals - (HCM) BFN
07/03/22 10:04 Hutchmed (China) Limited (HCM) Hutchmed receives $15 million from AstraZeneca for Saffron progress ALN
03/03/22 13:02 Hutchmed (China) Limited (HCM) EARNINGS REPORTS: Elementis swings to profit; Hutchmed changes CEO ALN
26/04/21 06:08 (HCM) Director Deals - (HCM) BFN
26/04/21 06:08 (HCM) Director Deals - (HCM) BFN
26/04/21 06:08 (HCM) Director Deals - (HCM) BFN
26/04/21 06:08 (HCM) Director Deals - (HCM) BFN
26/04/21 06:08 (HCM) Director Deals - (HCM) BFN
26/04/21 06:08 (HCM) Director Deals - (HCM) BFN
11/03/21 06:07 (HCM) Director Deals - (HCM) BFN
30/11/20 07:00 Hutchison China Medi (HCM) Total Voting Rights RNS
27/11/20 07:00 Hutchison China Medi (HCM) Notification of Dilution of Voting Rights RNS
17/11/20 07:00 Hutchison China Medi (HCM) US$100m Equity Investment by CPP Investments RNS
05/11/20 09:00 Hutchison China Medi (HCM) Chi-Med to Present HMPL-689 Clinical Data at ASH RNS
First     Previous